16.7
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gr…
Botulism is a severe neuroparalytic illness caused by the botulinum toxin, which is produced by Clostridium botulinum.
In adults, it occurs either after consuming food contaminated with preformed toxin or when the bacterium infects a wound and produces the toxin locally.
In localized infection, the bacterium synthesizes an inactive form of the botulinum toxin, composed of a heavy and a light chain linked by a disulfide bond.
When the toxin is ingested, it crosses intestinal epithelial cells through transcytosis and enters the bloodstream.
From there, it spreads into neuromuscular junctions and targets nerve endings that release acetylcholine.
The toxin enters the nerve cell through endocytosis.
Endosome acidification triggers cleavage of the disulfide bond, releasing the catalytically active light chain into the cytosol.
The light chain acts as a protease that cuts SNARE proteins needed for synaptic vesicle fusion and acetylcholine release.
Blocking acetylcholine release prevents muscle contraction, leading to weakness and flaccid paralysis.
View the full transcript and gain access to JoVE Core videos
Q1: How does Clostridium botulinum produce botulinum toxin?
Clostridium botulinum, a Gram-positive spore-forming anaerobe, synthesizes botulinum neurotoxin as an inactive polypeptide composed of a heavy chain and light chain linked by a disulfide bond. The bacterium produces toxin either when ingested as preformed toxin in contaminated food or when spores germinate in wounds or the intestine, releasing toxin into surrounding tissue or the bloodstream.
Q2: What is the difference between foodborne and infant botulism?
Foodborne botulism in adults results from ingesting preformed toxin absorbed through the intestine. Infant botulism occurs after spore ingestion, typically from honey, where spores germinate in the immature gut. Limited microbiota and reduced colonization resistance allow bacterial growth and continuous toxin production in situ, creating sustained toxin exposure rather than acute systemic exposure.
Q3: How does botulinum toxin enter and damage nerve cells?
The toxin crosses intestinal epithelial cells through transcytosis and enters the bloodstream, then spreads to neuromuscular junctions. At nerve endings, the heavy chain binds receptors and triggers endocytosis. Endosomal acidification releases the catalytically active light chain into the cytosol, where it acts as a protease to cleave SNARE proteins essential for synaptic vesicle fusion.
Q4: Why does botulinum toxin cause paralysis?
The light chain of botulinum toxin cleaves SNARE proteins—such as synaptobrevin, SNAP-25, or syntaxin—that are essential for acetylcholine release at the neuromuscular junction. Blocking acetylcholine release prevents muscle contraction, resulting in flaccid paralysis. Early symptoms include diplopia, ptosis, and dysphagia, and respiratory failure may develop without timely intervention.
Q5: How many botulinum toxin serotypes exist and which cause most foodborne cases?
Seven distinct botulinum neurotoxins are classified as serotypes A through G, produced by Clostridium botulinum and related clostridial species including C. sporogenes, C. novyi, C. baratii, C. butyricum, and C. argentinense. Serotypes A, B, E, and F are responsible for most foodborne botulism cases worldwide, with each serotype showing different patterns of occurrence.
Q6: What structural features enable botulinum toxin to block neurotransmission?
Botulinum neurotoxin is a 150 kDa zinc-dependent metalloprotease with a heavy chain enabling binding and internalization at cholinergic motor nerve terminals and a light chain functioning as a zinc-dependent endopeptidase. This two-chain structure, connected by a disulfide bond, allows the toxin to enter nerve cells and cleave SNARE proteins that mediate acetylcholine release.
Q7: How do patients recover from botulism?
Recovery from botulism depends on regeneration of motor nerve terminals, a process requiring weeks to months. Supportive care and prompt administration of antitoxin are critical to improving outcomes and preventing complications such as respiratory failure during the acute phase of the illness.